Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05863416
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-05-18
First Post:
2023-05-03
Brief Title:
Dexmedetomidine in Non-intubated VATS
Sponsor:
Tri-Service General Hospital
Organization:
Tri-Service General Hospital
Study Overview
Official Title:
Adjunctive Dexmedetomidine Infusion in Non-intubated Video-assisted Thoracoscopic Surgery
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This prospective study aims to evaluate the effectiveness of intraoperative DEX for postoperative analgesia and recovery after non-intubated VATS In addition the investigators observe the impact of DEX on anesthetic requirements hemodynamic parameters and adverse events during non-intubated VATS
Detailed Description:
The non-intubated thoracoscopic approach has been adapted for use with major lung resections The non-intubated VATS tries to minimize the adverse effects of tracheal intubation and general anesthesia such as intubation-related airway trauma ventilation-induced lung injury residual neuromuscular blockade and postoperative nausea and vomiting An adequate analgesia allows VATS to be performed in sedated patients and the potential adverse effects related to general anesthesia and selective ventilation can be avoided Dexmedetomidine DEX a highly selective alpha-2 receptor agonist is increasingly used in anesthesia with sedative hypnotic anxiolytic sympatholytic and analgesic effects It can also attenuate perioperative stress and inflammation and preserve the immunity of surgical patients which may contribute to reduced postoperative complications and improved clinical outcomes This study aims to evaluate the effectiveness of intraoperative DEX for postoperative analgesia and recovery after non-intubated VATS In addition the investigators observe the impact of DEX on anesthetic requirements hemodynamic parameters and adverse events during non-intubated VATS
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None